These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24721298)

  • 1. [The predictive value of plasma cystatin C for non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention].
    Yan S; Zhang X; Tian X; Li J; Zhuang L; Zhang X; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):10-3. PubMed ID: 24721298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of plasma cystatin C for acute coronary syndrome treated with percutaneous coronary intervention.
    Sun TW; Xu QY; Yao HM; Zhang XJ; Wu Q; Zhang JY; Li L; Zhang YZ; Kan QC; Guan FX; Wang LX
    Heart Lung; 2012; 41(5):456-62. PubMed ID: 22652172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome.
    Taglieri N; Fernandez-Berges DJ; Koenig W; Consuegra-Sanchez L; Fernandez JM; Robles NR; Sánchez PL; Beiras AC; Orbe PM; Kaski JC;
    Atherosclerosis; 2010 Mar; 209(1):300-5. PubMed ID: 19819453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of elevated cystatin C in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Akgul O; Uyarel H; Ergelen M; Pusuroglu H; Gul M; Turen S; Bulut U; Baycan OF; Ozal E; Cetin M; Yıldırım A; Uslu N
    J Crit Care; 2013 Oct; 28(5):882.e13-20. PubMed ID: 23683571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
    De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
    J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.
    Manzano-Fernández S; López-Cuenca A; Januzzi JL; Parra-Pallares S; Mateo-Martínez A; Sánchez-Martínez M; Pérez-Berbel P; Orenes-Piñero E; Romero-Aniorte AI; Avilés-Plaza F; Valdés-Chavarri M; Marín F
    Am J Cardiol; 2012 Nov; 110(9):1240-8. PubMed ID: 22818840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the ratio of neutrophil/lymphocyte and risk stratification, prognosis in patients with non-ST-elevation acute coronary syndrome].
    Wang Y; Jia SJ; Chi Z
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1784-1789. PubMed ID: 28647999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
    Angeli F; Verdecchia P; Savonitto S; Arraiz G; Zaninotto M; Broccatelli A; Cosma C; De Servi S; Sabino F; Briguori C; Ambrosio G; Cavallini C;
    EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message.
    Ferraro S; Santagostino M; Marano G; Colli E; Vendramin C; Maffé S; Rossi L; Galvani M; Panteghini M; Bongo AS
    Scand J Clin Lab Invest; 2012 Sep; 72(5):355-62. PubMed ID: 22486807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome.
    Fu Z; Qian G; Xue H; Guo J; Chen L; Yang X; Shen M; Dong W; Chen Y
    Clin Interv Aging; 2015; 10():1467-74. PubMed ID: 26396506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention.
    Brunetti ND; Quagliara D; Di Biase M
    Eur J Intern Med; 2008 Oct; 19(6):435-42. PubMed ID: 18848177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemoglobin: simply a laboratory value or a powerful predictor of risk in patients with acute coronary syndrome?].
    Ferreira M; António N; Gonçalves F; Monteiro P; Gonçalves L; Freitas M; Providência LA
    Rev Port Cardiol; 2012 Feb; 31(2):121-31. PubMed ID: 22244550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.